Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul C Braylan

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2004
Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasiasRaul C Braylan
Ejhaem|January 27, 2025
Myeloma with <i>BRAF</i> p.V600E mutation and atypical plasma cellsHuan Mo, Raul C Braylan
British Journal of Haematology|August 16, 2002
Regarding the loss of CD20 after rituximab therapyRonald Lee, Raul C Braylan
Seminars in Hematology|December 22, 2018
Advances in diagnostic hematopathologyKatherine R Calvo, Raul C Braylan
American Journal of Clinical Pathology|March 15, 2005
CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemiaRonald V Lee, Raul C Braylan, Lisa M Rimsza
Archives of Pathology & Laboratory Medicine|October 27, 2004
In hematopathology, love is everywhereSamer Z Al-Quran, Mousa Al-Abbadi, Raul C Braylan
Seminars in Hematology|December 22, 2018
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates<sup>☆</sup>Alina Dulau-Florea, Irina Maric, Katherine R Calvo, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanismKatherine J Walsh, Samer Z Al-Quran, Ying Li, et al.
International Journal of Clinical and Experimental Pathology|March 9, 2012
Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasiaDavid D Grier, Samer Z Al-Quran, Diana M Cardona, et al.
Molecular Cancer Therapeutics|August 30, 2008
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growthJacqueline Sayyah, Andrew Magis, David A Ostrov, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2004
Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasiasRaul C Braylan
Ejhaem|January 27, 2025
Myeloma with <i>BRAF</i> p.V600E mutation and atypical plasma cellsHuan Mo, Raul C Braylan
British Journal of Haematology|August 16, 2002
Regarding the loss of CD20 after rituximab therapyRonald Lee, Raul C Braylan
Seminars in Hematology|December 22, 2018
Advances in diagnostic hematopathologyKatherine R Calvo, Raul C Braylan
American Journal of Clinical Pathology|March 15, 2005
CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemiaRonald V Lee, Raul C Braylan, Lisa M Rimsza
Archives of Pathology & Laboratory Medicine|October 27, 2004
In hematopathology, love is everywhereSamer Z Al-Quran, Mousa Al-Abbadi, Raul C Braylan
Seminars in Hematology|December 22, 2018
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates<sup>☆</sup>Alina Dulau-Florea, Irina Maric, Katherine R Calvo, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanismKatherine J Walsh, Samer Z Al-Quran, Ying Li, et al.
International Journal of Clinical and Experimental Pathology|March 9, 2012
Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasiaDavid D Grier, Samer Z Al-Quran, Diana M Cardona, et al.
Molecular Cancer Therapeutics|August 30, 2008
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growthJacqueline Sayyah, Andrew Magis, David A Ostrov, et al.
Pageof 3